Table 3.
Results from the loglogistic modelling
| Variable | Coefficient | 95% CI | p Value | Marginal effect (weeks)‡ | 95% CI |
|---|---|---|---|---|---|
| STA* | −0.49 | −0.62 to −0.36 | <0.001 | −36.2 | −46.05 to −26.42 |
| Cancer* | −0.03 | −0.002 to 0.04 | 0.60 | −2.06 | −9.80 to 5.70 |
| STA × cancer | 0.13 | −0.05 to 0.30 | 0.15 | 9.23 | −3.36 to 21.81 |
| Drug* | 0.08 | −0.01 to 0.20 | 0.08 | 6.10 | −0.75 to 12.87 |
| Review* | −0.04 | −0.12 to 0.07 | 0.43 | −3.26 | −11.39 to 4.87 |
| Ever an appeal* | 0.60 | 0.50 to 0.67 | <0.001 | 42.83 | 35.50 to 50.17 |
| Year started† | 0.02 | −0.002 to 0.04 | 0.073 | 1.40 | −0.35 to 2.94 |
| Ln_γ | −2.06 | −2.20 to −1.91 | <0.001 | − | − |
Log likelihood=2.23; constant=4.04.
*Yes=1, no=0.
†Where values range between (200)1 and (20)10.
‡Indicates the independent contribution to the median to time to publication; values less than 0 indicate that variables are associated with a shorter time to guidance.